These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36374522)

  • 21. SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
    Finsterer J; Scorza FA
    Int J Infect Dis; 2020 Dec; 101():56. PubMed ID: 33002612
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to 'SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?'.
    Bagnato S; Boccagni C; Marino G; Prestandrea C; D'Agostino T; Rubino F
    Int J Infect Dis; 2020 Dec; 101():57. PubMed ID: 33002615
    [No Abstract]   [Full Text] [Related]  

  • 23. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology.
    Hejbøl EK; Harbo T; Agergaard J; Madsen LB; Pedersen TH; Østergaard LJ; Andersen H; Schrøder HD; Tankisi H
    Eur J Neurol; 2022 Sep; 29(9):2832-2841. PubMed ID: 35661354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does SARS-CoV-2 truly cause infectious myopathy?
    Finsterer J; Scorza FA
    J Formos Med Assoc; 2021 Mar; 120(3):1032-1033. PubMed ID: 32917481
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiological assessment in patients with COVID-19-related peripheral neuropathies and myopathies: a systematic review.
    Al-Mazidi S; Al-Dakhil L
    J Neurophysiol; 2023 Jan; 129(1):191-198. PubMed ID: 36475865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclude differentials before attributing post-COVID fatigue to myopathy.
    Finsterer J; Scorza FA
    Clin Neurophysiol; 2021 Sep; 132(9):2324-2325. PubMed ID: 34332866
    [No Abstract]   [Full Text] [Related]  

  • 27. Plexus-neuropathy due to ilio-psoas hematoma in 4 COVID patients.
    Pardal-Fernández JM; Garcia-Garcia J; Gutiérrez-Rubio JM; Segura T
    Med Clin (Barc); 2021 Apr; 156(8):410-411. PubMed ID: 33504435
    [No Abstract]   [Full Text] [Related]  

  • 28. Critical illness myopathy after COVID-19.
    Bagnato S; Boccagni C; Marino G; Prestandrea C; D'Agostino T; Rubino F
    Int J Infect Dis; 2020 Oct; 99():276-278. PubMed ID: 32763444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19.
    de Oliveira JADP; de Athaide MM; Rahman AU; de Mattos Barbosa MG; Jardim MM; Moraes MO; Pinheiro RO
    Front Cell Infect Microbiol; 2022; 12():815738. PubMed ID: 35281455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to letter to the editor "Does SARS-CoV-2 truly cause infectious myopathy?".
    Chang KC
    J Formos Med Assoc; 2021 Mar; 120(3):1034-1035. PubMed ID: 32921536
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical illness neuropathy and myopathy.
    Gutmann L; Gutmann L
    Arch Neurol; 1999 May; 56(5):527-8. PubMed ID: 10328246
    [No Abstract]   [Full Text] [Related]  

  • 32. Myopathic changes in patients with long-term fatigue after COVID-19.
    Agergaard J; Leth S; Pedersen TH; Harbo T; Blicher JU; Karlsson P; Østergaard L; Andersen H; Tankisi H
    Clin Neurophysiol; 2021 Aug; 132(8):1974-1981. PubMed ID: 34020890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral neuropathy and myopathy associated with carcinoma of the lung.
    Trojaborg W; Frantzen E; Andersen I
    Brain; 1969 Mar; 92(1):71-82. PubMed ID: 4304424
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
    Zhang Y; Chen X; Jia L; Zhang Y
    Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 may unravel metabolic myopathy mistaken for myasthenia.
    Finsterer J; Maeztu C
    Rev Esp Geriatr Gerontol; 2021; 56(2):124-125. PubMed ID: 33610379
    [No Abstract]   [Full Text] [Related]  

  • 36. Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit.
    Finsterer J; Scorza FA; Scorza CA; Fiorini AC
    Arq Neuropsiquiatr; 2021 Oct; 79(10):924-928. PubMed ID: 34287509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual evoked potential and nerve conduction study findings in patients recovered from COVID-19.
    Koskderelioglu A; Eskut N; Ortan P; Ozdemir HO; Tosun S
    Neurol Sci; 2022 Apr; 43(4):2285-2293. PubMed ID: 35028779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular complications of severe COVID-19 in paediatric patients: Medium-term follow-up.
    Avila-Smirnow D; Céspedes P; Reyes F; Angulo J; Cavagnaro A; Wegner A
    Neuromuscul Disord; 2022 Jun; 32(6):486-492. PubMed ID: 35562241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
    Sharifian-Dorche M; Huot P; Osherov M; Wen D; Saveriano A; Giacomini PS; Antel JP; Mowla A
    J Neurol Sci; 2020 Oct; 417():117085. PubMed ID: 32871412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-acute neurological consequences of COVID-19: an unequal burden.
    Nolen LT; Mukerji SS; Mejia NI
    Nat Med; 2022 Jan; 28(1):20-23. PubMed ID: 35039657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.